Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
about
Relationship of 24-hour ambulatory blood pressure and heart rate with markers of hepatic function in cirrhotic patients.The association between clinical symptoms, laboratory findings and serum endothelin 1 concentrations, in cirrhotic patients with and without hepatopulmonary syndrome.Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.Role of endothelin in systemic and portal resistance in cirrhosis.Increased endothelin receptor B and G protein coupled kinase-2 in the mesentery of portal hypertensive rats.Endothelin and hepatic wound healing.Pathophysiology of portal hypertension and its clinical links.Novel treatment options for portal hypertension.Emerging therapies for portal hypertension in cirrhosis.Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension.A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension.
P2860
Q30992956-1C24D19E-26D7-4975-B253-6F2C2022B4CAQ33596500-97FD321A-BAA3-4CC1-9A04-6880A1065CCEQ36000526-5091924A-9A4D-4AA0-BE4B-EE1CBF0547B1Q36564609-68C645A6-2E67-4D3C-ABDB-82057C0B00B2Q36759223-F5DE80D5-78C4-436E-9F04-C94F038857AAQ37855219-BE681998-BECA-4688-8FA1-861FC13D57C3Q38371453-043F82ED-470B-4D0A-AFD7-CBA5F2211C9CQ38680437-9A8166C1-8593-4220-8DFA-F3F9D7584E2FQ38826464-84C0DB60-B8CF-4AB9-A81E-9B853852DFA7Q40707200-193D0800-9F24-4E9B-895C-E23C8B1BFAD4Q44159478-AC7E0EBF-6A65-4507-8DED-14D4659F7CF0Q50635105-2F13587A-9ADB-4625-94F1-E48DCBC34D64
P2860
Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@ast
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@en
type
label
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@ast
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@en
prefLabel
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@ast
Endothelin-1 contributes to ma ...... a randomised controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Endothelin-1 contributes to ma ...... a randomised controlled trial
@en
P2093
P2860
P304
P356
10.1136/GUT.2005.077453
P407
P577
2006-01-24T00:00:00Z